Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,017 shares at $257.51 ($263K) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Open-market sale of $263k VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $255.40 | 40 | $10K | 3.9% |
| 2 | $257.51 | 280 | $72K | 27.4% |
| 3 | $257.51 | 280 | $72K | 27.4% |
| 4 | $258.90 | 120 | $31K | 11.8% |
| 5 | $259.75 | 120 | $31K | 11.9% |
| 6 | $260.82 | 80 |
| $21K |
| 7.9% |
| 7 | $261.91 | 91 | $24K | 9.1% |
| 8 | $264.37 | 6 | $2K | 0.6% |
| Total | $258.55 avg | 1,017 | $263K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |